Atherogenesis: A dysimmune disease;L'athérogenèse: Une maladie dysimmunitaire

Medecine/Sciences

Volumn 24, Issue 2, 2008, Pages 169-175

  Varthaman, Aditi ^a   Khallou Laschet, Jamila ^a   Thaunat, Olivier ^a   Caligiuri, Giuseppina ^a   Nicoletti, Antonino ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE DURATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; PATHOGENESIS; PHENOTYPE; REVIEW;

EID: 39649087387     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2008242169     Document Type: Review

References (52)

1. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerosis plaque formation in the apoliprotein E-deficient mouse. Proc Natl Acad Sci USA 1997 ; 94 : 4642-6.
2. + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000 ; 102 : 2919-22.
3. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993 ; 14 : 426-30.
4. Frostegard J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques : dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999 ; 145 : 33-43.
5. th Congress of the European Atherosclerosis Society. Atherosclerosis 2007 ; 111 (suppl) : 13-4.
6. Houtkamp MA, de Boer OJ, van der Loos CM, et al. Adventitial infiltrates associated with advanced atherosclerotic plaques : structural organization suggests generation of local humoral immune responses. J Pathol 2001 ; 193 : 263-9.
7. Yla-Herttuala S, Palinski W, Butler SW, et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994 ; 14 : 32-40.
8. Palinski W, Tangirala RK, Miller E, et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb 1995 ; 15 : 1569-76.
9. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992 ; 339 : 883-7.
10. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heatshock protein 65 with carotid atherosclerosis. Lancet 1993 ; 341 : 255-9.
11. Stemme S. T lymphocytes-role in atherosclerosis and interactions with vascular cells. University of Gothenburg, 1992.
12. Shaw PX, Horkko S, Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000 ; 105 : 1731-40.
13. Paulsson G, Zhou X, Tornquist E, Hansson GK. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000 ; 20 : 10-7.
14. Melian A, Geng YJ, Sukhova GK, et al. CD1 expression in human atherosclerosis : a potential mechanism for T cell activation by foam cells. Am J Pathol 1999 ; 155 : 775-86.
15. Kleindienst R, Xu Q, Willeit J, et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993 ; 142 : 1927-37.
16. Kanwar RK, Kanwar JR, Wang D, et al. Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001 ; 21 : 1991-7.
17. Benagiano M, D'Elios MM, Amedei A, et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol 2005 ; 174 : 6509-17.
18. George J, Harats D, Gilburd B, et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques : potential implications for lesion progression. Circulation 1999 ; 99 : 2227-30.
19. Vaarala O, Manttari M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995 ; 91 : 23-7.
20. Caligiuri G, Stahl D, Kaveri S, et al. Autoreactive antibody repertoire is perturbed in atherosclerotic patients. Lab Invest 2003 ; 83 : 939-47.
21. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina : pathogenetic implications. J Am Coll Cardiol 1998 ; 32 : 1295-304.
22. Caligiuri G, Paulsson G, Nicoletti A, et al. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000 ; 102 : 1114-9.
23. Gupta S, Pablo AM, Jiang XC, et al. IFNγ potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997 ; 99 : 2752-561.
24. Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 2001 ; 104 : 197-202.
25. Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003 ; 9 : 10-7.
26. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999 ; 85 : e17-24.
27. Binder CJ, Hartvigsen K, Chang MK, et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004 ; 114 : 427-37.
28. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003 ; 163 : 1117-25.
29. Kuiper J. European vascular genomics network. Toulouse, France, 2006.
30. Khallou-Laschet J, Caligiuri G, Groyer E, et al. The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease. Arterioscier Thromb Vasc Biol 2006 ; 26 : 353-8.
31. Rajavashisth T, Qiao JH, Tripathi S, et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest 1998 ; 101 : 2702-10.
32. Sun J, Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007 ; 13 : 719-24.
33. Nicoletti A, Paulsson G, Caligiuri G, Hansson GK. Induction of neonatal tolerance to oxidized-LDL reduces atherosclerosis susceptibility in apoE knockout mice. Mol Med 2000 ; 6 : 283-90.
34. Zhou X, Caligiuri G, Hamsten A, et al. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001 ; 21 : 108-14.
35. Caligiuri G, Khallou-Laschet J, Vandaele M, et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am Coll Cardiol 2008 ; 50 (sous presse).
36. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation : molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003 ; 9 : 736-43.
37. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 ; 109 : 745-53.
38. Afek A, George J, Gilburd B, et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 2000 ; 14 : 115-21.
39. Schett G, Xu Q, Amberger A, et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995 ; 96 : 2569-77.
40. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992 ; 12 : 789-99.
41. Harats D, Yacov N, Gilburd B, et al. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 2002 ; 40 : 1333-8.
42. George J, Afek A, Gilburd B, et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-giycoprotein I. Circulation 1998 ; 98 : 1108-15.
43. Tupin E, Nicoletti A, Elhage R, et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004 ; 199 : 417-22.
44. + T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 2006 ; 26 : 864-70.
45. George J, Harats D, Gilburd B, et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000 ; 102 : 1822-7.
46. Nicoletti A, Kaveri S, Caligiuri G, et al. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 1998 ; 102 : 910-8.
47. Mallat Z, Gojova A, Brun V, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 2003 ; 108 : 1232-7.
48. Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001 ; 89 : 930-4.
49. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 ; 12 : 178-80.
50. Wyplosz B, Capron L. Aspects infectieux de l'athérosclé rose. Med Sci (Paris) 2004 ; 20 : 169-74.
51. Caligiuri G. Rôle de l'immunité dans l'athé rosclérose et dans les syndromes coronariens aigus. Med Sci (Paris) 2004 ; 20 : 175-81.
52. Mallat Z, Tedgui A. Apoptose et syndromes coronariens aigus. Med Sci (Paris) 2004 ; 20 : 298-303.